These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 16860835)

  • 1. Interferon-gamma and interleukin-4 downregulate expression of the SARS coronavirus receptor ACE2 in Vero E6 cells.
    de Lang A; Osterhaus AD; Haagmans BL
    Virology; 2006 Sep; 353(2):474-81. PubMed ID: 16860835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV).
    Sainz B; Mossel EC; Peters CJ; Garry RF
    Virology; 2004 Nov; 329(1):11-7. PubMed ID: 15476870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synergistic interaction of interferon types I and II leads to marked reduction in severe acute respiratory syndrome-associated coronavirus replication and increase in the expression of mRNAs for interferon-induced proteins.
    Scagnolari C; Trombetti S; Alberelli A; Cicetti S; Bellarosa D; Longo R; Spanò A; Riva E; Clementi M; Antonelli G
    Intervirology; 2007; 50(2):156-60. PubMed ID: 17191018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons.
    Scagnolari C; Vicenzi E; Bellomi F; Stillitano MG; Pinna D; Poli G; Clementi M; Dianzani F; Antonelli G
    Antivir Ther; 2004 Dec; 9(6):1003-11. PubMed ID: 15651759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. siRNA silencing of angiotensin-converting enzyme 2 reduced severe acute respiratory syndrome-associated coronavirus replications in Vero E6 cells.
    Lu CY; Huang HY; Yang TH; Chang LY; Lee CY; Huang LM
    Eur J Clin Microbiol Infect Dis; 2008 Aug; 27(8):709-15. PubMed ID: 18449585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.
    Li W; Moore MJ; Vasilieva N; Sui J; Wong SK; Berne MA; Somasundaran M; Sullivan JL; Luzuriaga K; Greenough TC; Choe H; Farzan M
    Nature; 2003 Nov; 426(6965):450-4. PubMed ID: 14647384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein.
    Fukushi S; Mizutani T; Saijo M; Matsuyama S; Miyajima N; Taguchi F; Itamura S; Kurane I; Morikawa S
    J Gen Virol; 2005 Aug; 86(Pt 8):2269-2274. PubMed ID: 16033974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exogenous ACE2 expression allows refractory cell lines to support severe acute respiratory syndrome coronavirus replication.
    Mossel EC; Huang C; Narayanan K; Makino S; Tesh RB; Peters CJ
    J Virol; 2005 Mar; 79(6):3846-50. PubMed ID: 15731278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of SARS-CoV-2 by type I and type III interferons.
    Felgenhauer U; Schoen A; Gad HH; Hartmann R; Schaubmar AR; Failing K; Drosten C; Weber F
    J Biol Chem; 2020 Oct; 295(41):13958-13964. PubMed ID: 32587093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins.
    Wang SF; Tseng SP; Yen CH; Yang JY; Tsao CH; Shen CW; Chen KH; Liu FT; Liu WT; Chen YM; Huang JC
    Biochem Biophys Res Commun; 2014 Aug; 451(2):208-14. PubMed ID: 25073113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro inhibition of SARS virus replication by human interferons.
    Dahl H; Linde A; Strannegård O
    Scand J Infect Dis; 2004; 36(11-12):829-31. PubMed ID: 15764169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines.
    Morgenstern B; Michaelis M; Baer PC; Doerr HW; Cinatl J
    Biochem Biophys Res Commun; 2005 Jan; 326(4):905-8. PubMed ID: 15607755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor.
    Ge XY; Li JL; Yang XL; Chmura AA; Zhu G; Epstein JH; Mazet JK; Hu B; Zhang W; Peng C; Zhang YJ; Luo CM; Tan B; Wang N; Zhu Y; Crameri G; Zhang SY; Wang LF; Daszak P; Shi ZL
    Nature; 2013 Nov; 503(7477):535-8. PubMed ID: 24172901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63.
    Glowacka I; Bertram S; Herzog P; Pfefferle S; Steffen I; Muench MO; Simmons G; Hofmann H; Kuri T; Weber F; Eichler J; Drosten C; Pöhlmann S
    J Virol; 2010 Jan; 84(2):1198-205. PubMed ID: 19864379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin.
    Barnard DL; Day CW; Bailey K; Heiner M; Montgomery R; Lauridsen L; Winslow S; Hoopes J; Li JK; Lee J; Carson DA; Cottam HB; Sidwell RW
    Antiviral Res; 2006 Aug; 71(1):53-63. PubMed ID: 16621037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV.
    Lokugamage KG; Hage A; de Vries M; Valero-Jimenez AM; Schindewolf C; Dittmann M; Rajsbaum R; Menachery VD
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32938761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium.
    Sims AC; Burkett SE; Yount B; Pickles RJ
    Virus Res; 2008 Apr; 133(1):33-44. PubMed ID: 17451829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antiviral effect of interferon-beta against SARS-coronavirus is not mediated by MxA protein.
    Spiegel M; Pichlmair A; Mühlberger E; Haller O; Weber F
    J Clin Virol; 2004 Jul; 30(3):211-3. PubMed ID: 15135736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coordinate induction of IFN-alpha and -gamma by SARS-CoV also in the absence of virus replication.
    Castilletti C; Bordi L; Lalle E; Rozera G; Poccia F; Agrati C; Abbate I; Capobianchi MR
    Virology; 2005 Oct; 341(1):163-9. PubMed ID: 16095648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.